Business Standard

Tara Jewels hits lower circuit, slips below issue price

There are pending sell orders for 177,750 shares on the BSE and NSE

Related News

declined nearly 5% for the second day in a row, and was locked in lower circuit at Rs 219 on the BSE, with no buyers on the counter.

The stock of the Mumbai-based jewellery manufacturer and retailer got listed at Rs 242 on Thursday, is currently trading below its issue price of Rs 230 per share. A combined around 8,000 shares have already changed hands on the counter and there are pending sell orders for 177,750 shares on both the exchanges.

Tara Jewels has listed and admitted to dealings on the Exchange in the list of ‘T’ group of securities and the scrip will be in Trade-for-Trade (T2T) segment for 10 trading days.

Under the T2T segment, only delivery-based trading can be done and 100% value at risk margin is collected by the exchanges. If a scrip is shifted for settlement on T2T basis, selling/ buying of shares in that scrip results into giving/ taking delivery of shares at the gross level and no intra day netting off/ square off facility is permitted.

The company had raised Rs 180 crore through the initial public offers (IPO). The company proposed to use the net proceeds of issue for expenses of establishing retail stores and payment of loans.

Read more on:   
|
|

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Quick Links

Market News

Markets rise on ECB tide

World markets rallied on Friday after the European Central Bank decided on Thursday to pump a little over about euro 1 trillion to revive the ...

ECB's QE unlikely to result in widespread gains for all asset classes

Cheap money to seek high-yielding assets; prices of others like industrial metals, gold could settle

Sensex records sharpest seven-day rally since 2009

The Sensex surged 273 points on Friday to close at 29,278.84, and has rallied 1,932 points in the past seven trading days since January 15

Gold imports came to halt as discounts widened

High discounts are due to huge carry over stock of gold imported in November

GSK Pharma, select MNC stocks gain as Sebi eases delisting norm

In intra-day trade, GSK Pharma gained as much as 12% and ended 6.4% higher at Rs 3,347.45

 

Back to Top